https://oncdata.com/article/ef861f57-f466-40ca-99a5-df16b4430496Oncology Data Advisoren2026-11-14T02:49:50.278ZMolecular and Immunologic Profiling of HER2-Low Advanced Gastric Cancer https://oncdata.com/article/26bb6190-e429-4f97-b970-5e64b28bea83Oncology Data Advisoren2026-11-14T02:49:50.192ZPSA Screening Benefits and Harms: Systematic Review for the American Cancer Society Guideline Update https://oncdata.com/new-combination-approach-to-kmt2a-rearranged-infant-leukemiaOncology Data Advisoren2026-11-13T14:03:33.382ZA New Combination Approach to KMT2A-Rearranged Infant Leukemia https://oncdata.com/article/cd8bb946-2881-41fd-9ffe-5a96f549baaeOncology Data Advisoren2026-11-13T12:49:54.689ZPerioperative Camrelizumab (Investigational) With Chemotherapy Improves EFS in Resectable HNSCC https://oncdata.com/article/0590a61d-266b-4197-97c6-63ec39fc067aOncology Data Advisoren2026-11-13T12:49:54.486ZLong-Term Second Cancer Risks in Female Hodgkin Lymphoma Survivors Across Treatment Eras https://oncdata.com/article/a44f4ac1-3296-4898-9131-54948cdd3317Oncology Data Advisoren2026-11-12T22:49:17.075ZPrognostic Nomogram for Supratentorial H3 K27-Altered Diffuse Midline Glioma: IPD Meta-Analysis